Scott M Chadderdon
Overview
Explore the profile of Scott M Chadderdon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahr F, Chadderdon S
JACC Cardiovasc Interv
. 2025 Feb;
18(3):349-351.
PMID: 39939039
No abstract available.
2.
Duggal N, Engoren M, Sorajja P, Lim D, Rogers J, Chadderdon S, et al.
Circ Cardiovasc Interv
. 2025 Jan;
18(2):e014843.
PMID: 39873105
Background: The association, if any, between the transmitral mean pressure gradient (TMPG) after mitral transcatheter edge-to-edge repair and 1-year mortality is controversial in patients undergoing mitral transcatheter edge-to-edge repair with...
3.
Tang G, Zaid S, Hahn R, Aggarwal V, Alkhouli M, Aman E, et al.
JACC Cardiovasc Imaging
. 2024 Jul;
18(1):93-115.
PMID: 38970594
3-dimensional (3D) intracardiac echocardiography (ICE) is emerging as a promising complement and potential alternative to transesophageal echocardiography for imaging guidance in structural heart interventions. To establish standardized practices, our multidisciplinary...
4.
Chandrashekar P, Ashangari C, Chadderdon S
Interv Cardiol Clin
. 2024 Mar;
13(2):141-153.
PMID: 38432758
Echocardiographic imaging is the foundation for the evaluation of mitral valve dysfunction. Both transthoracic and transesophageal echocardiography provide insight into the anatomy, pathology, and classification mitral valve dysfunction. Echocardiography also...
5.
Kumar K, Simpson T, Golwala H, Chhatriwalla A, Chadderdon S, Smith R, et al.
J Interv Cardiol
. 2023 Dec;
2023:6617035.
PMID: 38149109
Background: Despite an association between operator volumes and procedural success, there remains an incomplete understanding of the contemporary utilization and procedural volumes for mitral valve transcatheter edge-to-edge repair (MTEER). We...
6.
Duggal N, Engoren M, Chadderdon S, Rodriguez E, Morse M, Vannan M, et al.
Am J Cardiol
. 2023 Dec;
213:99-105.
PMID: 38110022
The association, if any, between the effective regurgitant orifice area (EROA) to left ventricular end-diastolic volume (LVEDV) ratio and 1-year mortality is controversial in patients who undergo mitral transcatheter edge-to-edge...
7.
Marcoff L, Koulogiannis K, Aldaia L, Mediratta A, Chadderdon S, Makar M, et al.
JACC Cardiovasc Imaging
. 2023 Dec;
17(5):471-485.
PMID: 38099912
Background: The CLASP IID randomized trial (Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial) demonstrated the safety and effectiveness of the PASCAL system for mitral transcatheter edge-to-edge repair (M-TEER)...
8.
Kumar K, Osman M, Samhan A, Morris C, Chau T, Herman T, et al.
J Invasive Cardiol
. 2023 Jul;
35(6):E291-E293.
PMID: 37410745
Chest radiation therapy (XRT) has been associated with a higher rate of mortality following surgical aortic valve replacement. We performed a single-center retrospective analysis of patients with severe AS who...
9.
Chadderdon S, Eleid M, Thaden J, Makkar R, Nakamura M, Babaliaros V, et al.
Struct Heart
. 2023 Jun;
6(4):100071.
PMID: 37288338
Patients with severe symptomatic tricuspid regurgitation face a significant dilemma in treatment options, as the yearly mortality with medical therapy and the surgical mortality for tricuspid repair or replacement are...
10.
Kumar K, Byrne T, Simpson T, Samhan A, Shah R, Rodriguez J, et al.
Struct Heart
. 2023 Jun;
7(2):100130.
PMID: 37275596
Background: There is an incomplete understanding of the predictors of morbidity and mortality in patients with severe tricuspid regurgitation (TR). This study sought to identify key risk factors for all-cause...